NCT00269191View on ClinicalTrials.gov

A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

528

Participants

Timeline

Start Date

February 5, 2003

Primary Completion Date

November 7, 2003

Study Completion Date

November 21, 2003

Conditions

Osteoarthritis

Interventions

DRUG

MK0663, etoricoxib / Duration of Treatment 12 Weeks

DRUG

Placebo or Ibuprofen / Duration of Treatment 12 Weeks

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00269191 - A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED) | Biotech Hunter | Biotech Hunter